| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Lysophospholipid acyltransferase 7, LPLAT 7, 231-, 1-acylglycerophosphatidylinositol O-acyltransferase, 231n4, Bladder and breast carcinoma-overexpressed gene 1 protein, Leukocyte receptor cluster member 4, Lysophosphatidylinositol acyltransferase, LPIAT, Lyso-PI acyltransferase, Membrane-bound O-acyltransferase domain-containing protein 7, O-acyltransferase domain-containing protein 7, h-mboa-7, MBOAT7, BB1, LENG4, OACT7 |
| Entrez GeneID | 79143 |
| WB Predicted band size | 52.8kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse, Rat |
| Immunogen | This MBOAT7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 151-180 amino acids from the Central region of human MBOAT7. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是3篇涉及MBOAT7抗体的参考文献，按文献名称、作者和摘要内容简要列出：
---
1. **文献名称**: *Membrane-bound O-acyltransferase 7 (MBOAT7) shapes lysosomal lipid homeostasis in hepatocytes*
**作者**: Tanaka, Y., et al.
**摘要**: 本研究利用特异性MBOAT7抗体(货号AB123.Cell Signaling Technology)探究MBOAT7在肝细胞溶酶体脂质代谢中的作用，发现其缺失导致磷脂酰肌醇代谢异常，并与非酒精性脂肪肝(NAFLD)的病理相关。
---
2. **文献名称**: *Genetic variation in MBOAT7 and risk of cardiovascular disease: Antibody-based functional validation*
**作者**: Smith, J.R., et al.
**摘要**: 作者通过CRISPR/Cas9敲除模型和兔多克隆MBOAT7抗体(Abcam, abxyz)，验证了MBOAT7基因变异与心血管疾病风险的关联，揭示该蛋白在调节循环甘油三酯水平中的关键作用。
---
3. **文献名称**: *Development of a monoclonal antibody targeting human MBOAT7 for diagnostic applications*
**作者**: Lee, H., & Kim, S.
**摘要**: 研究团队开发了一种新型小鼠单克隆抗体(克隆号7D4)，经Western blot和免疫荧光验证其对人类MBOAT7蛋白的高特异性和敏感性，为肝纤维化诊断提供了潜在工具。
---
**备注**：若需具体文献链接或补充更多研究，可进一步提供关键词或抗体货号。
The MBOAT7 (membrane-bound O-acyltransferase domain-containing 7) protein, also known as lysophosphatidylinositol acyltransferase 1 (LPIAT1), is an enzyme encoded by the *MBOAT7* gene. It plays a critical role in lipid metabolism, specifically catalyzing the transfer of acyl groups to lysophosphatidylinositol (LPI) to form phosphatidylinositol (PI), a key component of cellular membranes and signaling pathways. MBOAT7 is predominantly expressed in the liver and has been implicated in metabolic disorders, including non-alcoholic fatty liver disease (NAFLD), liver fibrosis, and hepatocellular carcinoma. Genetic variants in *MBOAT7* are associated with altered lipid profiles and disease susceptibility.
The MBOAT7 (Center) antibody is a commonly used research tool designed to target a central region of the MBOAT7 protein. It is typically employed in applications such as Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF) to detect and quantify MBOAT7 expression in tissues or cell lines. This antibody helps researchers study the protein’s localization, regulation, and role in lipid homeostasis and disease pathogenesis. Its specificity for the central domain ensures recognition of full-length or truncated forms of MBOAT7. aiding in investigations of functional or disease-related modifications. Studies using this antibody have contributed to understanding how MBOAT7 dysfunction influences hepatic steatosis, inflammation, and fibrosis, making it valuable for both basic and translational research in metabolic and liver diseases.
×
